DOJ investigating Golden Valley-based Inspire’s marketing of sleep apnea device
The promotion and reimbursement practices for the medtech company’s implantable CPAP alternative are under scrutiny.
Dr Boreham’s Crucible: On a dream run, this biotech shows no sign of dozing on the job
Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...
Earnings call transcript: ResMed surpasses Q2 FY2025 expectations, stock dips
ResMed Inc . (NYSE:RMD) reported its financial results for the second quarter of fiscal year 2025, exceeding analysts' expectations with an earnings per share (EPS) of $2.43, surpassing the forecasted ...